KARACHI – As of July 24, 2021, the exchange rates for the Saudi Riyal (SAR) against the Pakistani Rupee (PKR) in the open market are as follows:
• Buying Rate: PKR 42.00 per Saudi Riyal
• Selling Rate: PKR 42.50 per Saudi Riyal
These rates are determined based on real-time trading activity and are subject to fluctuations throughout the day. We continuously update our data on an hourly basis to ensure that buyers and sellers get the most accurate and competitive conversion for Saudi Riyal to Pakistani Rupee. This ensures transparency and better decision-making for those engaged in currency exchange.
The exchange parity between the Saudi Riyal and the PKR is driven primarily by market demand and supply. Open market currency traders play a key role in setting these values, and they are influenced by factors such as remittance inflows from Saudi Arabia, the demand for SAR due to Hajj and Umrah travel, and the overall performance of the Pakistani rupee in the global forex landscape.
The importance of the Saudi Riyal in the Pakistani forex market cannot be understated, given the strong economic and labor ties between Pakistan and Saudi Arabia. A significant number of Pakistani expatriates work in Saudi Arabia and regularly send remittances back home in Riyals, making SAR one of the most traded foreign currencies in Pakistan after the US dollar.
As a result, both individuals and businesses closely monitor SAR to PKR rates. Whether it’s for travel, trade, or remittances, the value of the Saudi Riyal in rupee terms affects millions of people. The PKR’s performance against the Saudi Riyal also reflects broader economic indicators including foreign reserves, inflation, and overall investor confidence.
In summary, the current SAR to PKR exchange reflects a buying rate of PKR 42.00 and a selling rate of PKR 42.50. These rates are constantly shifting in response to the forex market’s dynamics. Those looking to exchange Saudi Riyals for rupees—or vice versa—are encouraged to stay informed with the latest updates to make well-timed financial decisions.